BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17379177)

  • 1. Flow cytometric screening of cell-penetrating peptides for their uptake into embryonic and adult stem cells.
    Manceur A; Wu A; Audet J
    Anal Biochem; 2007 May; 364(1):51-9. PubMed ID: 17379177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of cell-penetrating peptide-mediated transduction of adult hematopoietic stem cells.
    Manceur AP; Audet J
    Methods Mol Biol; 2009; 482():43-54. PubMed ID: 19089349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
    Ziegler A; Nervi P; Dürrenberger M; Seelig J
    Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas).
    Takayama K; Nakase I; Michiue H; Takeuchi T; Tomizawa K; Matsui H; Futaki S
    J Control Release; 2009 Sep; 138(2):128-33. PubMed ID: 19465072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creation of a novel cell penetrating peptide, using a random 18mer peptides library.
    Nomura T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Mukai Y; Sugita T; Imai S; Nagano K; Okamoto T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
    Pharmazie; 2007 Aug; 62(8):569-73. PubMed ID: 17867548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens.
    Oess S; Hildt E
    Gene Ther; 2000 May; 7(9):750-8. PubMed ID: 10822301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the impact of valency on the routing of arginine-rich peptides into eukaryotic cells.
    Kawamura KS; Sung M; Bolewska-Pedyczak E; Gariépy J
    Biochemistry; 2006 Jan; 45(4):1116-27. PubMed ID: 16430208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligoarginine vectors for intracellular delivery: design and cellular-uptake mechanisms.
    Futaki S
    Biopolymers; 2006; 84(3):241-9. PubMed ID: 16333858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live-cell analysis of cell penetration ability and toxicity of oligo-arginines.
    Tünnemann G; Ter-Avetisyan G; Martin RM; Stöckl M; Herrmann A; Cardoso MC
    J Pept Sci; 2008 Apr; 14(4):469-76. PubMed ID: 18069724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
    Chugh A; Eudes F
    FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo.
    Ho A; Schwarze SR; Mermelstein SJ; Waksman G; Dowdy SF
    Cancer Res; 2001 Jan; 61(2):474-7. PubMed ID: 11212234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.
    Devadas K; Boykins RA; Hardegen NJ; Philp D; Kleinman HK; Osa EO; Wang J; Clouse KA; Wahl LM; Hewlett IK; Rappaport J; Yamada KM; Dhawan S
    Peptides; 2006 Apr; 27(4):611-21. PubMed ID: 16256245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides.
    Duchardt F; Fotin-Mleczek M; Schwarz H; Fischer R; Brock R
    Traffic; 2007 Jul; 8(7):848-66. PubMed ID: 17587406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly efficient, nonpeptidic oligoguanidinium vectors that selectively internalize into mitochondria.
    Fernández-Carneado J; Van Gool M; Martos V; Castel S; Prados P; de Mendoza J; Giralt E
    J Am Chem Soc; 2005 Jan; 127(3):869-74. PubMed ID: 15656624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine-rich cell-penetrating peptides.
    Schmidt N; Mishra A; Lai GH; Wong GC
    FEBS Lett; 2010 May; 584(9):1806-13. PubMed ID: 19925791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-penetrating peptides are excluded from the mitochondrial matrix.
    Ross MF; Murphy MP
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):1072-4. PubMed ID: 15506968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of cell-penetrating peptide-mediated peptide delivery.
    Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
    Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis.
    Nakase I; Tadokoro A; Kawabata N; Takeuchi T; Katoh H; Hiramoto K; Negishi M; Nomizu M; Sugiura Y; Futaki S
    Biochemistry; 2007 Jan; 46(2):492-501. PubMed ID: 17209559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides.
    Gupta B; Levchenko TS; Torchilin VP
    Adv Drug Deliv Rev; 2005 Feb; 57(4):637-51. PubMed ID: 15722168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.